Royalty Pharma (RPRX)
(Delayed Data from NSDQ)
$28.76 USD
+0.69 (2.46%)
Updated May 2, 2024 04:00 PM ET
After-Market: $28.74 -0.02 (-0.07%) 4:52 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Earnings News For RPRX
-
Royalty Pharma (RPRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
-
Royalty Pharma: Q4 Earnings Snapshot
-
Royalty Pharma: Q3 Earnings Snapshot
-
Royalty Pharma Reports Third Quarter 2023 Results
-
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
-
Royalty Pharma (RPRX) Surpasses Q2 Earnings and Revenue Estimates
-
Royalty Pharma: Q2 Earnings Snapshot
-
Royalty Pharma Reports Second Quarter 2023 Results
-
Royalty Pharma (RPRX) Q1 Earnings and Revenues Top Estimates
-
Royalty Pharma: Q1 Earnings Snapshot
-
Royalty Pharma Reports First Quarter 2023 Results
-
Royalty Pharma (RPRX) Reports Next Week: Wall Street Expects Earnings Growth
-
Royalty Pharma (RPRX) Matches Q4 Earnings Estimates
-
Royalty Pharma: Q4 Earnings Snapshot
-
Royalty Pharma (RPRX) Surpasses Q3 Earnings and Revenue Estimates
-
Royalty Pharma: Q3 Earnings Snapshot
-
Royalty Pharma Reports Third Quarter 2022 Results
-
Royalty Pharma (RPRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Royalty Pharma (RPRX) Tops Q2 Earnings and Revenue Estimates
-
Royalty Pharma: Q2 Earnings Snapshot
-
Royalty Pharma Reports Second Quarter 2022 Results
-
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
-
Royalty Pharma (RPRX) Lags Q1 Earnings Estimates
-
Royalty Pharma (RPRX) Reports Next Week: Wall Street Expects Earnings Growth
-
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release